Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CardioComm Solutions Establishes 30 Minute ECG Reporting Response Times as HeartCheck PEN Sales and SMART Monitoring Service Demand Grows

V.EKG
CardioComm Solutions Establishes 30 Minute ECG Reporting Response Times as HeartCheck PEN Sales and SMART Monitoring Service Demand Grows

(via Thenewswire.ca)

Leveraging national health care call centre infrastructure, North American HeartCheck PEN Consumers will have around the clock access to rapid physician ECG interpretations.

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company"), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, today formally announced expansion of the Company's SMART Monitoring Service and infrastructure to meet consumer demand for faster ECG interpretation services.

CardioComm Solutions is the first provider of a complete, full cycle and market tested ECG monitoring service for the consumer market. "We have the most cost effective ECG screening solution available. With HeartCheck PEN devices in production, stable and expandable IT infrastructure to ensure high volume ECG transmissions, and now with medical call centre resourcing for ECG reporting response times within 30 minutes, 24 hours a day and 7 days a week, we stand alone," said Simi Grosman, member of the Board of Director for CardioComm Solutions.

CardioComm Solution's SMART Monitoring service operates similar to that of large, prescription only Independent Diagnostic Testing Facilities ("IDTF") in the USA. "The SMART Monitoring solution ensures that consumers will receive reliable and medically credible results," said Etienne Grima, Chief Executive Officer for CardioComm Solutions. "With the accuracy and stability of the service firmly managed, ensuring the timeliness of the SMART Monitoring responses to consumer demands was our next challenge. We have met the market expectation for rapid ECG interpretation through associating our current ECG reading capabilities under a strategic partnership with Humble, Texas based SPI Scanning LLC ("SPI")."

"CardioComm Solutions is well known in the ECG and arrhythmia monitoring business world. Many of our key staff have been drawn from other IDTF facilities where CardioComm Solutions products have been implemented and are well respected. We are excited to have entered into this relationship in support of the HeartCheck PEN and SMART Monitoring service and view this to be an important and industry altering medical monitoring advancement. SPI has a mandate to keep ahead of the competition and look towards the adoption of faster and better technologies, especially when it will meet the needs of many people who are worried about capturing accurate cardiac rhythm changes when they occur. We have the capabilities, experience and scalability to ensure the stringent requirements for rapid and high quality ECG readings are met without exception. We look forward to supporting CardioComm Solutions as they challenge conventional home telemedicine technologies to adopt remote ECG acquisition and centralized ECG interpretation capabilities and to expand their global launch of the SMART Monitoring service and HeartCheck PEN sales," said Tony Spires, Chief Executive Officer for SPI.

Consumers purchasing the HeartCheck PEN ECG will have access to CardioComm Solutions' SMART Monitoring ECG service, the free GEMS Home software and a first free physician ECG interpretation. After the free interpretation, the HeartCheck PEN can be enabled to display the ECG waveform at no additional cost. The Company will promote the sale of the HeartCheck PEN and SMART Monitoring service to 40 year and older consumers interested in the preservation of their health, as well as those at risk for developing arrhythmia based cardiac disease due to underlying conditions especially due to hypertension and diabetes and those taking high risk medications.

"At a price point of $12.50, with a rapid turnaround time for physician ECG interpretation, regardless of country and time of origin and utilizing highly credentialed software technologies, CardioComm Solutions is positioned to be the one-stop solution and global leader in consumer home ECG/arrhythmia monitoring services," added Grima.

About SPI Scanning LLC

SPI LLC is National Healthcare Testing Corporation established under US Federal guidelines as an IDTF and provides Holter and Event scanning services to hospitals and doctor's offices across the world. Offering turnkey solutions, SPI will supply, install, and maintain the required hardware and software resources for their accounts through all start up and growth cycle periods. SPI also specializes in over flow scanning to assist busy centers with rapid ECG processing by certified professionals.

About CardioComm Solutions

CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with offices in Victoria, B.C.

FOR FURTHER INFORMATION PLEASE CONTACT:

Etienne Grima, Chief Executive Officer

1-877-977-9425

egrima@cardiocommsolutions.com

www.cardiocommsolutions.com

Forward-looking statements

This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Copyright (c) 2013 TheNewswire - All rights reserved.